FDA Warns Public About Products Posing Heavy-Metal Exposure Risks
This article was originally published in The Rose Sheet
Executive Summary
FDA lab analysis of Alikay Naturals' Bentonite Me Baby identified elevated lead levels posing potential risks to consumers, the agency says in a Jan. 28 safety alert, while the company suggests FDA has mischaracterized its product and intended use. A same-day consumer warning cites hazardous mercury content in a skin cream largely available in Spanish-speaking communities.
You may also be interested in...
FDA Going Through Enforcement Toolkit To Address Bentonite Me Baby
FDA lab analysis found lead in Alikay Naturals' Bentonite Me Baby clay at a level of 37.5 ppm, according to a March 16 warning letter citing the purported cosmetic as an unapproved and misbranded drug. The agency cautioned consumers about the product in January and seems to be urging the company to recall it, which may draw attention to the authority FDA currently lacks under federal food, drug and cosmetic law.
In Brief: FDA, EPA Sharing Data; Industry Lead-In-Cosmetics Petition Goes Unanswered; More
FDA could use data collected under the Toxic Substances Control Act to inform its risk-assessment work, a March 16 update indicates, announcing a memorandum of understanding between FDA and the Environmental Protection Agency. More news in brief.
FDA Issues Final Lead-In-Lipstick Report, Postpones Decision On Cosmetic Lead Limits
FDA’s expanded survey of lead levels in lipstick examined 400 products on the market, finding an average amount of 1.11 ppm, comparable with its initial test of 20 lipsticks, which averaged 1.07 ppm lead content.